Centene | CNC - Sales Revenues

Stock Price
58.25
Daily Change
-0.45 -0.77%
Monthly
49.36%
Yearly
-5.71%
Q2 Forecast
54.80

Centene reported $49.94B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Acadia Healthcare USD 828.8M 7.3M Mar/2026
Addus HomeCare USD 363.6M 9.5M Mar/2026
Brookdale Senior Living USD 764.86M 10.77M Mar/2026
Cardinal Health USD 60.9B 4.73B Mar/2026
Centene USD 49.94B 210M Mar/2026
Charles River Laboratories USD 995.8M 1.6M Mar/2026
Cigna USD 68.52B 3.95B Mar/2026
Community Health Systems USD 3.11B 19M Dec/2025
Cross Country Healthcare USD 236.76M 13.29M Dec/2025
CVS Health USD 100.4B 5.3B Mar/2026
DaVita Healthcare Partners USD 3.42B 200M Mar/2026
eHealth USD 58.41M 7.45M Sep/2024
Elevance Health USD 49.5B 200M Mar/2026
Encompass Health USD 1.59B 50M Mar/2026
Ensign USD 1.39B 30M Mar/2026
HCA USD 19.11B 400M Mar/2026
Henry Schein USD 3.37B 30M Mar/2026
Humana USD 39.65B 7.13B Mar/2026
IQVIA Holdings USD 4.15B 210M Mar/2026
Laboratory Of America USD 3.54B 20M Mar/2026
McKesson USD 92.3B 13.86B Mar/2026
Molina Healthcare USD 10.8B 580M Mar/2026
Option Care Health USD 1.35B 120M Mar/2026
Pediatrix Medical Group USD 493.77M 896K Dec/2025
Quest Diagnostics USD 2.9B 90M Mar/2026
Select Medical USD 1.42B 20M Mar/2026
Tenet Healthcare USD 5.37B 160M Mar/2026
UnitedHealth USD 111.7B 1.5B Mar/2026
Universal Health Services USD 4.49B 0 Mar/2026
Veradigm USD 142.52M 9.38M Dec/2022